0

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for Diabetic Macular Oedema: A Literature Review

Horace Massa, Anindyt M Nagar, Athanasios Vergados, Panagiotis Dadoukis, Sudeshna Patra, Georgios D Panos

J Int Med Res. 2019 Jan;47(1):31-43.

PMID: 30556449

Abstract:

Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP67732-A Fluocinolone Acetonide Fluocinolone Acetonide 67-73-2 Price
qrcode